Opioid Prescriber Training Program Update Part 1

NYS mandated training program

Enduring online program

2 contact hours (0.20 CEUs)

Initial Release Date:  2/8/2019 

Expiration Date:  8/30/2021

Target Audience

Prescribers with a DEA number and medical residents prescribing under a facility DEA number.

On this page:

Program Overview

The purpose of New York State (NYS) Prescription Drug Overdose (PDO) Prevention Program is to advance and evaluate comprehensive state-level interventions for preventing prescription drug overuse, misuse, abuse, and overdose. Effective July 22, 2016, Public Health Law Article 33 §3309-a was updated to require prescribers with a Drug Enforcement Administration (DEA) number and medical residents prescribing under a facility DEA number to complete a minimum of a 3-hours of course work or training in pain management, palliative care and addiction. Included in the PDO Prevention Program objectives, is an educational component for provider. The education outreach program will focus on updating providers on the Centers for Disease Control and Prevention (CDC) Guidelines for Prescribing Opioids for Chronic Pain- United States, 2016 and the topics included in the educational mandate. This part 1 educational portion of the program will provide providers with 2.0 hours of CME (each) at no cost to the provider.

Objectives

· Describe the pathophysiology and general approaches for pain management in the ambulatory setting.

· Describe approaches for managing acute pain and how they would differ from approaches for managing chronic pain.

· Outline clinical guidelines for appropriate prescribing of opioid analgesics.

· List the Federal and New York State requirements for prescribing controlled substances. 

This Opioid Prescriber Training Program Part I covers four of the mandated topic areas:

Pain management

Appropriate prescribing

Managing acute pain

State and Federal requirements for prescribing controlled substances

Program Components

This program contains a pre-test, video presentation, educational handout material, post-test, and a program evaluation. Credit will be awarded upon successful completion of the post-test activity with a score of 70% or better. 

Please be sure to attest once you have completed the course at

https://www.health.ny.gov/professionals/narcotic/mandatory_prescriber_education/neat.htm

Speaker(s)

Speaker.

Romanth Waghmarae, MD, DABA, FACIP, FIPP

Assistant Clinical Professor Anesthesia-McMaster UniversityRomanth

Lecturer Daemen College-PA program

Research Assistant Professor- SUNY-UB School of Pharmacy

Editorial Board AJPM, Pain Physician 

Speaker.

Karl D. Fiebelkorn, MBA, RPh

Senior Associate Dean

Student, Professional & Community Affairs

Associate Professor

Pharmacy Practice & Administration

UB School of Pharmacy and Pharmaceutical Sciences 

Cost

There is no fee associated with this program for prescribers.

Pharmacists are welcome to participate in this program for a nominal fee of $20.00 and ACPE accreditation has been awarded for this activity.

Program Support

The program is supported by the Cooperative Agreement 1 NU17CE002742-01, funded by the Centers for Disease Control and Prevention and by the New York State Department of Health. The contents are solely the responsibility of the University at Buffalo School of Pharmacy and Pharmaceutical Sciences, and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the Department of Health and Human Services.

New York State Department of Health Guidance Document

https://www.health.ny.gov/professionals/narcotic/mandatory_prescriber_education/docs/guidance.pdf

Recommended Browsers

Recommended Web Browsers:

How to Enable Cookies:

Please do not use Internet Explorer as your browser for this program. 

Accreditation Information

Prescribers and Dentists will receive, via email, your ACCME or DDS certification of attendance and letter of completion within 48 hours after successful completion of the activity. 

(Please check your spam or junk mail folder if you do not see it in your inbox.)

Accreditation Types:  ACCME, ADA/CERP, ACPE

Certification for Prescribers:

The University at Buffalo Jacobs School of Medicine and Biomedical Sciences is accredited by the ACCME to provide continuing medical education for physicians.

The University at Buffalo School Jacobs School of Medicine and Biomedical Sciences designates this Enduring Material activity, Course Code #9057, for a maximum of 2.0 AMA PRA Category 1 Credit TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Certification for Dentists:

UB Continuing Dental Education is an ADA CERP Recognized Provider.  ADA CERP is a service of the American Dental Association to assist dental professionals in identifying qualified providers of continuing dental accreditation.  ADA CERP does not approve or endorse individual courses or instructors, not does it imply acceptance of credit hours by boards of dentistry.  UB Continuing Dental Education designates this activity for 2 continuing education credits.

Accreditation for Pharmacists:

The University at Buffalo School of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This knowledge-based enduring activity has been assigned ACPE# 0044-0000-19-018-H01-P and will award 2 contact hours (0.20 CEUs) of continuing pharmacy education credit. Credit will be uploaded to the CPE Monitor to those who complete all components of this activity and achieve a successful score of 70% or greater on the post-test. 

Pharmacists will receive, via email, the letter of completion and ACPE credit will be uploaded directly to the CPE Monitor.                                       

Initial release date: 2/8/2019  Expiration Date: 8/30/2021

ACPE.

Questions?